Investigating Post-Genocide Intergenerational Trauma on Rwandan Youth in Calgary

Summary

This study aims to understand how the 1994 Genocide against the Tutsi in Rwanda affected young Rwandans living in Calgary, Canada. We will have focus group discussions with ten Rwandan youths aged 18 to 30 whose parents were targeted for killing because of their Tutsi ethnic group. In them, we will talk about their experiences and feelings about the genocide. We will also discuss its impact on their lives. The discussions will help us learn about their mental health, identity, and social attitudes. By analyzing their experiences, we will find better ways to support young people dealing with the effects of this trauma. Participants will be recruited through posters. They may join by reaching out to us through the contact information provided using a QR code/link or by email.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 30

Accepts healthy participants: Yes

Inclusion criteria:

Rwandan individuals who:
1) are between the ages of 18-30 years old
2) grew up in and completed high school in Rwanda
3) grew up in and completed high school in Calgary
4) currently reside in Calgary
5) whose parents were targeted based on their ethnicity

Exclusion criteria:

Rwandan individuals who:
1) are below 18 or beyond 30 years of age
2) are between the ages of 18-30 years old, but haven't completed high school
3) currently reside outside Calgary
4) whose parents were not targeted for the genocide killings based on their ethnicity.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

If you wish to participate, please contact Blessing Kwikiriza through the provided email.

Principal investigator:

Regine King

Clinical trial:

No

REB-ID:

REB24-0757